BEDFORD, Mass.--(BUSINESS WIRE)--May 8, 2018--
Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic
and regenerative medicines company specializing in therapeutics based on
its proprietary hyaluronic
acid (“HA”) technology, today announced plans to showcase its
innovative commercial and pipeline portfolio at the 18th bi-annual
European Society for Sports Traumatology, Knee Surgery and Arthroscopy
(ESSKA) Congress, being held in Glasgow, Scotland on May 9-12, 2018.
“We look forward to showcasing our pioneering orthopedic and
regenerative medicine solutions, including CINGAL and HYALOFAST, at the
18th ESSKA Congress,” said Joseph Darling, President and CEO, Anika
Therapeutics. “Our participation represents an important opportunity to
highlight real-world evidence from CINGAL and HYALOFAST to the 4,000
medical experts in the field of sports traumatology, knee surgery and
arthroscopy participating from all over the world.”
Company-Sponsored Physician Education
Location: Anika Booth
#51, Hall no.4, Scottish Event Campus
Wednesday, May 9, 2018
10:00 - 11:00 Dr. Mikolaj Wrobel, OrtopediKa Clinic in Warsaw, Poland,
will be available at the booth for guided training sessions with the
HYALOFAST Virtual Surgical Simulator.
Thursday, May 10, 2018
15:30 - 16:30 Dr. Alberto Gobbi, OASI Bioresearch Foundation, Milano –
Italy, will be available at the booth for guided training sessions
with the HYALOFAST Virtual Surgical Simulator.
Company-Sponsored Lunch Symposium
Location: Room Boisdale
1/2, Scottish Event Campus
Friday, May 11, 2018
12:30 - 13:30 Boisdale 1/2 Room, Lunch Symposium: HYALOFASTOne-step
Procedure: Best Practice and New Evidence in Cartilage Repair
Dr. Alberto Gobbi, OASI Bioresearch Foundation, Milano – Italy
Speakers and Topics:
Dr. Alberto Gobbi, OASI Bioresearch Foundation, Milano – Italy:
HYALOFASTLong-Term Clinical Outcomes in the Treatment
of Full-Thickness Cartilage Lesions of the Knee
Dr. Bogusław Sadlik, St. Luke Clinic, Bielsko Biala – Poland: HYALOFASTArthroscopic Implantation in the Knee: Pitfalls, Pearls and
MRI Based RehabProtocol
Prof. Stephan Nehrer, Danube University, Krems – Austria: HYALOFASTin the Treatment of Cartilage Defects in the Ankle:
Surgical Technique and Clinical Results
About ESSKA Congress
(European Society for Sports Traumatology, Knee Surgery and Arthroscopy)
Congress is expected to include 4,000 medical experts in the field of
sports traumatology, knee surgery and arthroscopy from all over the
world. It offers many opportunities to interact with orthopedic
surgeons, physio therapists and other medical professionals.
About Anika Therapeutics, Inc.
Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated orthopedic
and regenerative medicines company based in Bedford, Massachusetts.
Anika is committed to improving the lives of patients with degenerative
orthopedic diseases and traumatic conditions with clinically meaningful
therapies along the continuum of care, from palliative pain management
to regenerative cartilage repair. The Company has over two decades of
global expertise developing, manufacturing, and commercializing more
than 20 products based on its proprietary hyaluronic
acid (HA) technology.
Anika's orthopedic medicine portfolio includes ORTHOVISC®,
which alleviate pain and restore joint function by replenishing depleted
HA, and HYALOFAST,
a solid HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit www.anikatherapeutics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180508006512/en/
Source: Anika Therapeutics, Inc.
Anika Therapeutics, Inc.
Sylvia Cheung, 781-457-9000